Co-amoxiclav 250mg/62mg/5ml oral suspension
BNF presentation 0501013K0AAAIAI within chapter Infections. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0501013K0AAAIAI
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
5,734
NHS spend (£)
£47,892.92
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 1,176 |
| February 2025 | 7 |
| December 2024 | 352 |
| November 2024 | 1,131 |
| October 2024 | 828 |
| September 2024 | 2 |
| August 2024 | 22 |
| July 2024 | 375 |
| May 2024 | 113 |
| July 2021 | 232 |
| June 2021 | 179 |
| December 2020 | 588 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 38 | No data available |
| Unknown pharmacy | 30 | No data available |
| Unknown pharmacy | 28 | No data available |
| Unknown pharmacy | 27 | No data available |
| Unknown pharmacy | 27 | No data available |
| Unknown pharmacy | 26 | No data available |
| Unknown pharmacy | 26 | No data available |
| Unknown pharmacy | 23 | No data available |
| Unknown pharmacy | 23 | No data available |
| Unknown pharmacy | 22 | No data available |